1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VERTEX PHARMACEUTICALS, INC.
Vertex Pharmaceuticals, Inc. XNAS: VRTX

Vertex Pharmaceuticals, Inc. Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...

Read More
395.25 -0.87 (-0.22%)
52W Low on Aug 11, 2025
1.4M
XNAS Volume

XNAS 08 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Vertex Pharmaceuticals, Inc. is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
38.5 / 100
Momentum Score
Technically Neutral
37.4 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM
Analyst Price Target
480
1Yr Price target upside is 21%
24 analysts

3

S

19

W

1

O

2

T

SWOT Analysis

Vertex Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..